Results 81 to 90 of about 411,749 (186)

The Effect of Insulin Detemir on the Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus

open access: yes, 2008
Aim: Since there is limited number of studies in medical literature regarding the efficiency of in-sulin detemir, decrease in number of night hypoglycemia, weight changes and the improvement the lipid profile in pediatric and adolescent age group, we ...
Ece Böber   +4 more
core  

Insulin Analogues (Insulin Detemir and Insulin Aspart) Versus Traditional Human Insulins (NPH Insulin Regular Human Insulin) in Basal Bolus Therapy for Patients with Type-I Diabetes Mellitus

open access: yesPakistan Armed Forces Medical Journal
Objective: To compare the effect of Insulin analogues (Insulin Detemir and Insulin Aspart) versus Traditional Human Insulins (NPH Insulin Regular Human Insulin) in basal bolus therapy for patients with Type-I Diabetes Mellitus.
Muhammad Hamza Zaheer   +5 more
doaj   +1 more source

Insulin detemir (Levemir)

open access: yes, 2005
peer reviewedInsulin detemir (Levemir) is a soluble long acting human insulin analogue acylated with a 14-carbon fatty acid. The fatty acid modification allows insulin detemir to reversibly bind to albumin, thereby providing slow absorption and a ...
Scheen, André   +3 more
core  

The Efficacy of Insulin Detemir Versus Neutral Protamine Hagedorn Insulin in Treatment of Gestational Diabetes Mellitus During Pregnancy

open access: yesPakistan Journal of Medical Research
Background: The gestational diabetes mellitus (GDM) is one of the most common medical conditions during pregnancy. Insulin is considered to be safe in pregnancy.
Rukhsana Babar   +5 more
doaj   +2 more sources

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Yanbu cohort of the A 1 chieve study

open access: yesIndian Journal of Endocrinology and Metabolism, 2013
Background: The A 1 chieve, a multicentric (28 countries), 24-week, non-interventional study evaluated the safety and effectiveness of insulin detemir, biphasic insulin aspart and insulin aspart in people with T2DM (n = 66,726) in routine clinical care ...
Moody El Harby, Ahmed Saeed
doaj   +1 more source

Assessment of efficiency of application of various analogues of insulin in treatment of diabetes type 2 [PDF]

open access: yesСаратовский научно-медицинский журнал, 2014
Purpose: to estimate efficiency of treatment of analogues of insulin Glargin and insulin Detemir in patients with diabetes type 2. Material and methods.
Rodionova T.l., Orlova M.M.
doaj  

Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes

open access: yes, 2010
P>AimsThe efficacy of two basal insulins, insulin lispro protamine suspension (ILPS) and insulin detemir, was compared in basal-bolus regimens in Type 1 diabetes.MethodsIn this 32-week, multinational, parallel-group, randomized, controlled trial, adult ...
A. R. Chacra   +12 more
core   +1 more source

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2

open access: yesКачественная клиническая практика, 2018
Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin   +5 more
doaj  

Does insulin detemir have a role in reducing risk of insulin-associated weight gain?

open access: yes, 2007
Weight gain is often perceived as inevitable with insulin therapy, particularly as we strive for tight glycaemic control and are using increasingly proactive insulin titration regimes.
Davies, M, Hermansen, K
core   +1 more source

Basal insulin analogues in the diabetes mellitus type 2 control — economic aspects

open access: yesКачественная клиническая практика, 2018
Economic aspects of insulin analogues — glargine and detemir — in the control of diabetes mellitus type 2 (DM 2) has been prepared in according to needs of the Russian health care system.
D. Yu. Belousov, E. V. Afanasyeva
doaj  

Home - About - Disclaimer - Privacy